PDA’s newest technical report Process Validation: A Lifecycle Approach presents timely and real world guidance for the application of a lifecycle approach to process validation. The lifecycle approach has been the focus of recent process validation guidance from major regulatory agencies and represents a significant change in expectations in this area. This new technical report, part of the PCMO(sm) initiative, will review requirements for process validation studies across the three-stage approach defined by FDA and also discuss best practices for integration with supporting Quality Systems.
PDA TR 60
Original price was: $325.00.$162.00Current price is: $162.00.
Technical Report No. 60 (TR 60) Process Validation: A Lifecycle Approach
Parenteral Drug Association , 02/01/2013
Pages: 102















